Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,518 public trials 2,834 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML

NCT04620681

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

NCT01203722

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)

NCT05005442

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: City of Hope Comprehensive Cancer Center-Hematology ( Site 0024) Duarte, California, United States

University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0021 Aurora, Colorado, United States

University of Chicago Medical Center ( Site 0005) Chicago, Illinois, United States

Henry Ford Hospital ( Site 0003) Detroit, Michigan, United States

View all 65 locations

View Trial Details

Completed

A Study of the Safety and Effectiveness of Eltrombopag in Combination With Immunosuppressive Therapy (IST) in Korean Pediatric Patients With Treatment Naïve Severe Aplastic Anemia

NCT07415083

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemia, +4 more
Locations: Novartis East Hanover, New Jersey, United States

View Trial Details

Completed

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

NCT02833610

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Emory University Hospital Atlanta, Georgia, United States

Massachusetts general Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Mass General/North Shore Cancer Center Danvers, Massachusetts, United States

View Trial Details

Completed

Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

NCT05804032

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Universitätsklinikum Krems Krems, Austria

Ordensklinikum Linz Linz, Austria

Landeskrankenhaus Feldkirch-Rankweil Rankweil, Austria

Universitätsklinikum der Paracelsus, 3. Med. Abteilung/Onkologie Ambulanz Salzburg, Austria

View all 91 locations

View Trial Details

Completed

Coverage and Cost of Care Links- Telehealth

NCT07409662

Conditions: Behavior, Behavioral Symptoms, Financial Stress, +8 more
Locations: University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy

NCT04810546

Conditions: Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +15 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

View Trial Details

Completed

A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States

NCT06851065

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: RTI Health Solutions Raleigh, North Carolina, United States

View Trial Details

Completed

Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing

NCT04356781

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +16 more
Locations: The Walton Centre NHS Foundation Trust Liverpool, Merseyside, United Kingdom

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions